Follow
Solid Tumor Cancer
Solid tumors are abnormal tissue without a liquid area. Most solid tumors are named for the location or type of cell in which they develop, such as breast cancer, prostate cancer, or skin cancer. While solid tumors can be benign, when malignant they are classified as solid tumor cancer.
What's Popular in Solid Tumor Cancer
-
FEB 22, 2024Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as ...Written By: Brian G. MorrealeFEB 15, 2024Immunology
Scientists have dedicated their lives to finding a cure for cancer. America became a science hub for cancer research, pa ...Written By: Brian G. MorrealeFEB 01, 2024Immunology
The innate immune system is the first response the body initiates when exposed to foreign pathogens. A myriad of cells a ...Written By: Brian G. MorrealeJAN 11, 2024Immunology
Immunotherapy has transformed the way we treat cancer patients. An alternative approach to chemotherapy, immunotherapy e ...Written By: Brian G. MorrealeJAN 04, 2024Immunology
Since the clinical application of anti-CTLA-4 and anti-PD-1 immunotherapy, treatments targeting the immune system (immun ...Written By: Brian G. Morreale
FEB 22, 2024
Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as
...
Written By:
Brian G. Morreale
FEB 15, 2024
Immunology
Scientists have dedicated their lives to finding a cure for cancer. America became a science hub for cancer research, pa
...
Written By:
Brian G. Morreale
FEB 01, 2024
Immunology
The innate immune system is the first response the body initiates when exposed to foreign pathogens. A myriad of cells a
...
Written By:
Brian G. Morreale
JAN 11, 2024
Immunology
Immunotherapy has transformed the way we treat cancer patients. An alternative approach to chemotherapy, immunotherapy e
...
Written By:
Brian G. Morreale
JAN 04, 2024
Immunology
Since the clinical application of anti-CTLA-4 and anti-PD-1 immunotherapy, treatments targeting the immune system (immun
...
Written By:
Brian G. Morreale
DEC 28, 2023
Immunology
New technologies are rapidly transforming the way scientists study disease, particularly cancer. Due to unique biologica
...
Written By:
Brian G. Morreale
DEC 14, 2023
Immunology
A novel immune cell therapy known as Chimeric Antigen Receptor (CAR) T cell therapy has recently demonstrated efficacy i
...
Written By:
Brian G. Morreale
NOV 30, 2023
Immunology
Engineered immune cells have been the topic of investigation for the last few decades. Just 11 years ago a child was tre
...
Written By:
Brian G. Morreale
NOV 16, 2023
Immunology
Cancer is very difficult to treat due to various components that therapies must address to effectively kill or lyse tumo
...
Written By:
Brian G. Morreale
-
On DemandC.E. CREDITS
Proliferation biomarkers are proteins that are up-regulated in growing cells. Immunological staining of tumor tissue can provide an indication of the aggressivity of the tumor and provide in...
NOV 30, 2023 | 12:00 PM
C.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...
Speaker:
Dr. Shuko Harada
, Dr. Aakash Desai, MBBS, MPH
Presented at: Precision Medicine in Solid Tumors
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
NOV 16, 2023 | 10:00 AM
Across various stages of the clinical oncology workflow, from panel design to genomic testing and molecular tumor boards, the identification and validation of actionable genomic alterations...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
On Demand
C.E. CREDITS
Proliferation biomarkers are proteins that are up-regulated in growing cells. Immunological staining of tumor tissue can provide an indication of the aggressivity of the tumor and provide in...
NOV 30, 2023 | 12:00 PM
C.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...
Speaker:
Dr. Shuko Harada
, Dr. Aakash Desai, MBBS, MPH
Presented at: Precision Medicine in Solid Tumors
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
NOV 16, 2023 | 10:00 AM
Across various stages of the clinical oncology workflow, from panel design to genomic testing and molecular tumor boards, the identification and validation of actionable genomic alterations...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 26, 2023 | 8:00 AM
In the era of advanced biotechnology, automation plays a crucial role in accelerating cancer research. Next-generation sequencing (NGS) technology has revolutionized cancer research, but lab...
Speaker:
Nicholas Lodato, Ph.D.
, Enrique Neumann, Ph.D.
Sponsored By: Beckman Coulter Life Sciences
OCT 12, 2023 | 8:00 AM
Patient-derived tumoroids, also known as cancer organoids, hold potential as cost-effective models for cancer immunotherapy research. Patient-derived tumor models, which mimic the tumor micr...
OCT 11, 2023 | 9:00 PM
Epigenetic modifications such as DNA methylation have long shown promise as potential biomarkers to diagnose and guide treatment of many human diseases, including multiple types of cancers....
Speaker:
Dr. Lucia Anna Muscarella, Ph.D.
, Dr. Cristina Guillén, Ph.D.
Sponsored By: Thermo Fisher Scientific
SEP 28, 2023 | 7:00 AM
Webinars will be available for unlimited on-demand viewing after live event. Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the AS...
-
C.E. CREDITS
DXRX LabTalks are a dynamic webinar series led by the foremost experts within the DXRX Lab Network. These sessions are designed to connect you with cutting-edge knowledge and provide invalua...MAR 20, 2024 | 8:30 PM PDT
The premier event in NGS education is now available on demand. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each y...JUN 12, 2024 | 1:00 PM PDTC.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...SEP 13, 2023 | 10:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...SEP 12, 2023 | 8:00 AM PDT
Tandem Mass Tags (TMT) have revolutionized the field of mass spectrometry by enabling simultaneous identification and quantification of protein expression from multiple samples in a single L...
C.E. CREDITS
DXRX LabTalks are a dynamic webinar series led by the foremost experts within the DXRX Lab Network. These sessions are designed to connect you with cutting-edge knowledge and provide invalua...
MAR 20, 2024
| 8:30 PM PDT
The premier event in NGS education is now available on demand. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each y...
JUN 12, 2024
| 1:00 PM PDT
C.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
SEP 13, 2023
| 10:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
SEP 12, 2023
| 8:00 AM PDT
Tandem Mass Tags (TMT) have revolutionized the field of mass spectrometry by enabling simultaneous identification and quantification of protein expression from multiple samples in a single L...
JUL 26, 2023
| 8:00 AM PDT
GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, le...
MAR 30, 2023
| 12:00 AM PDT
Don’t miss the premier event in NGS education. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each year to adv...
OCT 19, 2022
| 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
OCT 04, 2022
| 5:30 AM PDT
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....